GAIN THERAPEUTICS INC (GANX)
US36269B1052 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 5.03M | 2.91M | 3.26M | N/A | N/A | |||
| Cash Equivalents | 6.77M | 4.40M | 33.62M | 7.49M | 300.00K | |||
| Marketable Securities | 5.00M | 12.83M | 33.62M | N/A | N/A | |||
| Receivables | 242.58K | 190.00K | 200.00K | 70.00K | 40.00K | |||
| Other Current Assets | 741.64K | 760.00K | 650.00K | 1.43M | 80.00K | |||
| Total Current Assets | 17.78M | 21.09M | 37.72M | 8.99M | 430.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 778.55K | 1.02M | 1.21M | 550.00K | 220.00K | |||
| Investments And Advances | 0.00 | 1.94M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 51.91K | 50.00K | 50.00K | 60.00K | 10.00K | |||
| Total Non-Current Assets | 830.46K | 3.01M | 1.27M | 610.00K | 230.00K | |||
| TOTAL ASSETS | 18.61M | 24.10M | 38.99M | 9.60M | 660.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 118.80K | 110.00K | 100.00K | 20.00K | 0.00 | |||
| Accrued Expenses | 1.97M | 1.97M | 1.37M | 800.00K | 310.00K | |||
| Accounts Payable | 1.32M | 1.63M | 560.00K | 960.00K | 150.00K | |||
| Other Current Liabilities | 1.54M | 420.00K | 520.00K | 330.00K | 410.00K | |||
| Total Current Liabilities | 4.95M | 4.13M | 2.55M | 2.11M | 880.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 449.05K | 500.00K | 590.00K | 720.00K | 0.00 | |||
| Other Non-Current Liabilities | 632.10K | 600.00K | 1.02M | 570.00K | 230.00K | |||
| Total Non-Current Liabilities | 1.08M | 1.09M | 1.62M | 1.29M | 230.00K | |||
| TOTAL LIABILITIES | 6.03M | 5.22M | 4.17M | 3.40M | 1.11M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -60.78M | -38.52M | -20.93M | -7.03M | -3.46M | |||
| Additional Paid In Capital | 73.11M | 57.36M | 55.83M | 13.39M | 3.09M | |||
| Common Shares | 1.62K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 247.24K | 40.00K | -90.00K | -150.00K | -80.00K | |||
| Shares Outstanding | 16.21M | 11.88M | 11.88M | 11.33M | 11.33M | |||
| Tangible Book Value per Share | 0.78 | 1.59 | 2.93 | 0.55 | -0.04 | |||
| Total Shareholders' Equity | 12.58M | 18.88M | 34.82M | 6.20M | -450.00K | |||
| TOTAL LIABILITIES AND EQUITY | 18.61M | 24.10M | 38.99M | 9.60M | 660.00K | |||
| Statistics | ||||||||
| Debt/Equity | 0.04 | 0.03 | 0.02 | 0.12 | N/A | |||
| Current Ratio | 3.59 | 5.11 | 14.79 | 4.26 | 0.49 | |||
| Return On Assets (ROA) | -119.66% | -72.99% | -35.62% | -37.29% | -331.82% | |||
| Return On Equity (ROE) | -177.03% | -93.17% | -39.89% | -57.74% | N/A | |||
All data in USD